[Nuclear oncology update].
Service de médecine nucléaire, Centre Jean-Perrin, 63011 Clermont-Ferrand.
J
J
Maublant
I
I
Resche
F
F
Giammarile
C
C
Corone
J C
JC
Artus
D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D001940:Breast / Q000000981:diagnostic imaging; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D009942:Organometallic Compounds / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010455:Peptides; D011868:Radioisotopes / Q000627:therapeutic use; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D017256:Technetium Tc 99m Sestamibi
D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D010455:Peptides; D011868:Radioisotopes; D019275:Radiopharmaceuticals; C061972:samarium Sm-153 lexidronam; D017256:Technetium Tc 99m Sestamibi